# Intravitreal and Intracameral DEX in NPDR

> **NCT06951087** · PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Affiliated Hospital of Nantong University** · enrollment: 80 (estimated)

## Conditions studied

- Non-Proliferative Diabetic Retinopathy

## Interventions

- **DRUG:** Dexamethasone sodium phosphate

## Key facts

- **NCT ID:** NCT06951087
- **Lead sponsor:** Affiliated Hospital of Nantong University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-01-31
- **Primary completion:** 2025-04-20
- **Final completion:** 2025-06-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06951087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06951087, "Intravitreal and Intracameral DEX in NPDR". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06951087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*